Dotmatics SLAS2023 Resources
Dotmatics, a global leader in R&D scientific software, offers integrated end-to-end solutions for biology, chemistry, and data management, showcased at SLAS 2023 with resources including eBooks and demos on biologics and small molecule discovery, as well as an integration with GraphPad Prism to enhance scientific data visualization and analysis.
What is Dotmatics?
Dotmatics is a global leader in R&D scientific software that connects science, data, and decision-making. Combining a workflow and data platform with best-of-breed applications, Dotmatics offers end-to-end solutions for biology, chemistry, formulations, data management, flow cytometry, and more.
Prism by Dotmatics
Prism Integration: Templated Export of Dotmatics Data into Prism
Watch Dotmatics + Prism in action to see how the integration can accelerate research and expand visualization and analysis capabilities.
Overview: The GraphPad Prism Solution
Learn how you can achieve enhanced analysis and visualization for your scientific research with GraphPad Prism.
Download: The GraphPad Prism Solution
Download Solution Resources at SLAS 2023
Biologics Discovery
eBook: Optimizing Biologics Discovery
The pressure to innovate in biologics discovery is extraordinarily high. In this eBook, you will learn how to overcome this pressure with modern solutions to improve access to novel therapies.
Download: Optimizing Biologic Discovery
Small Molecule Discovery
Overview: Dotmatics Small Molecule Discovery Solution
Download: Small Molecule Discovery Solution
Demo: Small Molecule Discovery in Dotmatics
Small Molecule Standard Demo Webinar
eBook: Optimizing Small Molecule Discovery
With rising pressure to do more with less, companies need to adopt processes and technologies that will help them drive innovation while controlling costs.
In this eBook, learn how to address common challenges in small molecule drug discovery so you can ensure data is trustworthy and traceable, improve productivity and collaboration, speed up research, and reduce technical debt and total cost of ownership.
Download: Optimizing Small Molecule Discovery
Webinar: 3 Key Considerations When Implementing AI in Drug Discovery
In this webinar, three keys to implementing AI in drug discovery are discussed: reasonable expectations, clean data, and collaboration.
See Dotmatics in Action
Fill out the form to request a free demonstration of Dotmatics. By talking to an expert, you can discover how a unified solution can address your specific needs.
Related
Our 11 Most-Read Blogs of 2023: AI, Biologics, ELNs, and More
Dotmatics' top blogs of 2023 highlight key scientific advancements including the convergence of small molecule and biologic drug development, the integration and comparison of LIMS and ELN systems for enhanced lab data management, and strategies to minimize human errors in biologics research through automation and calibration.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
NBC News: How AI is Transforming Drug Discovery
In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline fragmented data systems and manual workflows, thereby accelerating and improving the efficiency of drug discovery.
Discover Dotmatics: London
The Discover Dotmatics event on October 3rd, 2024, at The Ivy Asia St Pauls in London offers an afternoon of expert presentations on the latest Dotmatics platform updates and Dotmatics Luma, including a talk by Abzena, followed by networking with canapés and drinks from 2:00pm to 5:00pm.
The Rise of Biotech: Why Smaller Companies Are Outpacing Big Pharma on Innovation
Smaller biotech companies are increasingly outpacing big pharmaceutical firms in new molecular entity approvals due to their greater agility, willingness to take risks, and freedom to innovate despite funding challenges, with over half of upcoming blockbuster drug launches expected from first-time launchers who face higher risks but also potential for significant success.